This page contains supplementary information to support a poster presented at the 18th Annual Meeting of ISMPP (International Society for Medical Publication Professionals), May 9-11, 2022.
Cactus Communications commissioned a survey of pharma/biotech and associated industry professionals to understand the progress that the industry has made in terms of patient centricity and the barriers that are encountered in achieving greater patient involvement. The pharma journal PM360 conducted this study in collaboration with Litchfield Research, an independent research firm based in Roswell, GA. A total of 31 industry professionals participated in this survey, and they described medical affairs, clinical trials, and commercialization as their main areas of focus.
To understand what patient centricity means to different pharma, biotech, and other associated organizations, the current state of patient involvement in drug development and clinical research publication, and the barriers to greater patient involvement.
Survey Questionnaire and Responses:MAPS_Survey_Summary_Report_9May22-002-1
Share this post
About the author
Cactus Life Sciences
Cactus Life Sciences helps pharma, biotech, and medical device organizations worldwide with content strategy, development, and data. We work with medical affairs to disseminate insight-driven information to healthcare professionals, payors, and patients in a range of formats.